Balance Sheet
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Gsk (GLAXF) Equity Ratio (2016 - 2025)

Gsk has reported Equity Ratio over the past 10 years, most recently at 0.27 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.27 for Q4 2025, up 16.55% from a year ago — trailing twelve months through Dec 2025 was 0.07 (up 34.58% YoY), and the annual figure for FY2025 was 0.27, up 16.55%.
  • Equity Ratio for Q4 2025 was 0.27 at Gsk, up from 0.23 in the prior quarter.
  • Over the last five years, Equity Ratio for GLAXF hit a ceiling of 0.27 in Q4 2025 and a floor of 0.18 in Q4 2022.
  • Median Equity Ratio over the past 5 years was 0.23 (2023), compared with a mean of 0.22.
  • Biggest five-year swings in Equity Ratio: fell 7.42% in 2022 and later increased 28.37% in 2023.
  • Gsk's Equity Ratio stood at 0.19 in 2021, then fell by 7.42% to 0.18 in 2022, then rose by 28.37% to 0.23 in 2023, then grew by 1.64% to 0.23 in 2024, then increased by 16.55% to 0.27 in 2025.
  • The last three reported values for Equity Ratio were 0.27 (Q4 2025), 0.23 (Q4 2024), and 0.23 (Q4 2023) per Business Quant data.